Is a folic acid supplement safer to use with hydroxychloroquine (Plaquenil) than turmeric in a 33-year-old woman with rheumatoid arthritis who is planning pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Folic Acid Supplement is Safer with Hydroxychloroquine than Turmeric

Yes, folic acid supplementation is definitively safer to use with hydroxychloroquine (Plaquenil) than turmeric for a woman with rheumatoid arthritis planning pregnancy. Folic acid is specifically recommended by major rheumatology guidelines for pregnancy planning and has no known adverse interactions with hydroxychloroquine, while turmeric lacks safety data in this context and may interfere with disease control 1, 2.

Why Folic Acid is the Clear Choice

Hydroxychloroquine Safety Profile in Pregnancy

  • Hydroxychloroquine is strongly recommended to continue throughout pregnancy for women with rheumatoid arthritis and should never be discontinued 1, 2
  • The American College of Rheumatology classifies hydroxychloroquine as one of the safest DMARDs during pregnancy, with a "++" rating for pre-conception, pregnancy, and breastfeeding 1
  • Hydroxychloroquine has no known interactions with folic acid and the two can be safely combined 3

Folic Acid is Essential for Pregnancy Planning

  • The US Preventive Services Task Force recommends that all persons planning pregnancy take 0.4 to 0.8 mg (400 to 800 μg) of folic acid daily to prevent neural tube defects 4
  • Folic acid supplementation has substantial net benefit with high certainty of evidence for preventing congenital malformations 4
  • Women with rheumatoid arthritis planning pregnancy should begin folic acid at least 3 months before conception 5

Specific Relevance to Rheumatoid Arthritis Treatment

  • If sulfasalazine is part of the treatment regimen (another pregnancy-compatible DMARD), folic acid supplementation becomes mandatory because sulfasalazine inhibits folate absorption 2, 5
  • Folic acid at 1-2 mg daily improves tolerance of methotrexate (though methotrexate must be discontinued 1-3 months before conception) 3
  • Combined therapy with hydroxychloroquine and folic acid has been studied in rheumatoid arthritis with good safety profiles 3

Why Turmeric is Not Recommended

Lack of Safety Data

  • Turmeric (curcumin) has no established safety profile during pregnancy or in combination with hydroxychloroquine in pregnant women
  • There are no guidelines from the American College of Rheumatology, European League Against Rheumatism, or other major societies recommending turmeric for rheumatoid arthritis during pregnancy planning
  • The evidence base for turmeric in rheumatoid arthritis is insufficient to support its use when planning pregnancy

Potential for Inadequate Disease Control

  • Active rheumatic disease increases risk of adverse pregnancy outcomes including preterm birth, stillbirth, and neonatal complications 6
  • Optimal disease control must be achieved before conception using evidence-based medications 2
  • Relying on unproven supplements like turmeric instead of established therapies could compromise disease control

Practical Algorithm for This Patient

Immediate Actions (3+ Months Before Conception)

  1. Start folic acid 0.4-0.8 mg daily (can use up to 1 mg daily for women with rheumatoid arthritis) 4, 7
  2. Continue hydroxychloroquine without interruption 1, 2
  3. Discontinue any teratogenic DMARDs if present (methotrexate, leflunomide, mycophenolate) and transition to pregnancy-compatible alternatives 2

Ongoing Management

  • Maintain folic acid supplementation throughout pregnancy and lactation 8, 4
  • Monitor disease activity and adjust pregnancy-compatible DMARDs as needed (hydroxychloroquine, sulfasalazine, azathioprine, TNF inhibitors) 1, 2
  • If sulfasalazine is added to the regimen, ensure folic acid dose is at least 1 mg daily 2, 5

Critical Pitfalls to Avoid

Do Not Discontinue Hydroxychloroquine

  • Abrupt discontinuation when pregnancy is diagnosed can cause disease flares that harm both mother and fetus 2
  • Hydroxychloroquine should be continued throughout all trimesters and during breastfeeding 1, 2

Do Not Rely on Unproven Supplements

  • Using turmeric or other supplements without evidence-based efficacy may lead to inadequate disease control 2
  • Active disease at conception increases risks of preterm delivery, low birth weight, and pregnancy loss 6

Do Not Delay Folic Acid Supplementation

  • Neural tube defects occur in the first 28 days of pregnancy, often before a woman knows she is pregnant 4
  • Folic acid must be started at least 3 months before attempting conception for maximum benefit 7, 5

Monitor for Vitamin B12 Deficiency

  • Folic acid in doses above 0.1 mg daily may mask pernicious anemia while allowing neurologic complications to progress 8
  • If the patient has risk factors for B12 deficiency (strict vegetarian diet, gastric surgery, prolonged metformin use), check B12 levels before starting high-dose folic acid 9

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

DMARDs Safe During Pregnancy and Preconception Planning

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Sulfasalazine Use During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cyclosporine Use During Pregnancy: Safety, Dosing, Monitoring, and Disease‑Specific Guidance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

How safe are folic acid supplements?

Archives of internal medicine, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.